Literature DB >> 20150768

Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?

Meejeon Roh1, Sarki A Abdulkadir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20150768      PMCID： PMC3024832          DOI： 10.4161/cbt.9.8.11309

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  25 in total

1.  Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion.

Authors:  A Pedram; M Razandi; R M Hu; E R Levin
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

2.  Endothelin-1 as a mediator of endothelial cell-pericyte interactions in bovine brain capillaries.

Authors:  M P Dehouck; P Vigne; G Torpier; J P Breittmayer; R Cecchelli; C Frelin
Journal:  J Cereb Blood Flow Metab       Date:  1997-04       Impact factor: 6.200

3.  Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial.

Authors:  Michael A Carducci; Robert J Padley; Jurgen Breul; Nicholas J Vogelzang; Bernard A Zonnenberg; Danai D Daliani; Claude C Schulman; Azmi A Nabulsi; Rod A Humerickhouse; Mark A Weinberg; Jennifer L Schmitt; Joel B Nelson
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

4.  Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging.

Authors:  Justin M Drake; Curtis L Gabriel; Michael D Henry
Journal:  Clin Exp Metastasis       Date:  2006-05-16       Impact factor: 5.150

5.  Endothelin attenuates apoptosis in human smooth muscle cells.

Authors:  J R Wu-Wong; W J Chiou; R Dickinson; T J Opgenorth
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

6.  Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan.

Authors:  Joel B Nelson; Azmi A Nabulsi; Nicholas J Vogelzang; Jurgen Breul; Bernard A Zonnenberg; Danai D Daliani; Claude C Schulman; Michael A Carducci
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

7.  A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases.

Authors:  Juan Juan Yin; Khalid S Mohammad; Sanna M Käkönen; Stephen Harris; J Ruth Wu-Wong; Jerry L Wessale; Robert J Padley; I Ross Garrett; John M Chirgwin; Theresa A Guise
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-26       Impact factor: 11.205

8.  Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate.

Authors:  J B Nelson; S P Hedican; D J George; A H Reddi; S Piantadosi; M A Eisenberger; J W Simons
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

Review 9.  The endothelin axis: emerging role in cancer.

Authors:  Joel Nelson; Anna Bagnato; Bruno Battistini; Perry Nisen
Journal:  Nat Rev Cancer       Date:  2003-02       Impact factor: 60.716

10.  Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.

Authors:  J B Nelson; K Chan-Tack; S P Hedican; S R Magnuson; T J Opgenorth; G S Bova; J W Simons
Journal:  Cancer Res       Date:  1996-02-15       Impact factor: 12.701
View more
  1 in total

1.  [German Ophthalmology Internationally].

Authors:  T Kohnen
Journal:  Ophthalmologe       Date:  2017-09       Impact factor: 1.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.